Staphylococcus aureus protects its immune‐evasion proteins against degradation by neutrophil serine proteases

Neutrophils store large quantities of neutrophil serine proteases (NSPs) that contribute, via multiple mechanisms, to antibacterial immune defences. Even though neutrophils are indispensable in fighting Staphylococcus aureus infections, the importance of NSPs in anti‐staphylococcal defence is yet unknown. However, the fact that S. aureus produces three highly specific inhibitors for NSPs [the extracellular adherence proteins (EAPs) Eap, EapH1 and EapH2], suggests that these proteases are important for host defences against this bacterium. In this study we demonstrate that NSPs can inactivate secreted virulence factors of S. aureus and that EAP proteins function to prevent this degradation. Specifically, we find that a large group of S. aureus immune‐evasion proteins is vulnerable to proteolytic inactivation by NSPs. In most cases, NSP cleavage leads to functional inactivation of virulence proteins. Interestingly, proteins with similar immune‐escape functions appeared to have differential cleavage sensitivity towards NSPs. Using targeted mutagenesis and complementation analyses in S. aureus, we demonstrate that all EAP proteins can protect other virulence factors from NSP degradation in complex bacterial supernatants. These findings show that NSPs inactivate S. aureus virulence factors. Moreover, the protection by EAP proteins can explain why this antibacterial function of NSPs was masked in previous studies. Furthermore, our results indicate that therapeutic inactivation of EAP proteins can help to restore the natural host immune defences against S. aureus.

[1]  V. Rutten,et al.  Bovine Staphylococcus aureus Secretes the Leukocidin LukMF′ To Kill Migrating Neutrophils through CCR1 , 2015, mBio.

[2]  K. Ramyar,et al.  Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors , 2014, Proceedings of the National Academy of Sciences.

[3]  Evelien T. M. Berends,et al.  Distinct localization of the complement C5b‐9 complex on Gram‐positive bacteria , 2013, Cellular microbiology.

[4]  R. Nijland,et al.  Neutrophils versus Staphylococcus aureus: a biological tug of war. , 2013, Annual review of microbiology.

[5]  F. Vandenesch,et al.  The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. , 2013, Cell host & microbe.

[6]  P. Zipfel,et al.  Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b , 2012, PloS one.

[7]  Oliver Schilling,et al.  NSP4, an elastase-related protease in human neutrophils with arginine specificity , 2012, Proceedings of the National Academy of Sciences.

[8]  L. Miller,et al.  Immunity against Staphylococcus aureus cutaneous infections , 2011, Nature Reviews Immunology.

[9]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[10]  J. Köhl,et al.  Functional basis for complement evasion by staphylococcal superantigen‐like 7 , 2010, Cellular microbiology.

[11]  A. Horswill,et al.  agr-Dependent Interactions of Staphylococcus aureus USA300 with Human Polymorphonuclear Neutrophils , 2010, Journal of Innate Immunity.

[12]  J. V. van Strijp,et al.  A Homolog of Formyl Peptide Receptor-Like 1 (FPRL1) Inhibitor from Staphylococcus aureus (FPRL1 Inhibitory Protein) That Inhibits FPRL1 and FPR1 , 2009, The Journal of Immunology.

[13]  J. Weiser,et al.  Human Neutrophils Kill Streptococcus pneumoniae via Serine Proteases1 , 2009, The Journal of Immunology.

[14]  M. Hijnen,et al.  Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus , 2009, BMC Immunology.

[15]  S. Lindman,et al.  Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus--an anti-inflammatory protein. , 2009, Protein expression and purification.

[16]  S. Achilefu,et al.  Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa1 , 2008, The Journal of Immunology.

[17]  Eric P. Skaar,et al.  Neutrophil Microbicides Induce a Pathogen Survival Response in Community-Associated Methicillin-Resistant Staphylococcus aureus1 , 2008, The Journal of Immunology.

[18]  J. Köhl,et al.  Staphylococcal complement evasion by various convertase-blocking molecules , 2007, The Journal of experimental medicine.

[19]  P. Gros,et al.  Staphylococcal Complement Inhibitor: Structure and Active Sites1 , 2007, The Journal of Immunology.

[20]  P. Lenting,et al.  Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. , 2007, Blood.

[21]  J. V. van Strijp,et al.  A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 11 , 2006, The Journal of Immunology.

[22]  W. V. van Wamel,et al.  Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus , 2006, Cellular microbiology.

[23]  K. Preissner,et al.  Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus , 2006, The Journal of experimental medicine.

[24]  R. Liskamp,et al.  The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. , 2005, Journal of molecular biology.

[25]  Robert B Sim,et al.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases , 2005, Nature Immunology.

[26]  Adam Zemla,et al.  The Crystal Structures of EAP Domains from Staphylococcus aureus Reveal an Unexpected Homology to Bacterial Superantigens* , 2005, Journal of Biological Chemistry.

[27]  R. Liskamp,et al.  N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor , 2004, The Journal of Immunology.

[28]  E. Prossnitz,et al.  Chemotaxis Inhibitory Protein of Staphylococcus aureus Binds Specifically to the C5a and Formylated Peptide Receptor , 2004, The Journal of Immunology.

[29]  J. Schröder,et al.  Human leukocyte elastase and cathepsin G are specific inhibitors of C5a‐dependent neutrophil enzyme release and chemotaxis , 2004, Experimental dermatology.

[30]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[31]  Andreas Peschel,et al.  Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent , 2004, The Journal of experimental medicine.

[32]  S. Bahr,et al.  Neutrophil Serine Proteinases Cleave Bacterial Flagellin, Abrogating Its Host Response-Inducing Activity 1 , 2004, The Journal of Immunology.

[33]  N. Borregaard,et al.  Neutrophil granules and secretory vesicles in inflammation. , 2003, Microbes and infection.

[34]  L. Juliano,et al.  Discriminating between the Activities of Human Neutrophil Elastase and Proteinase 3 Using Serpin-derived Fluorogenic Substrates* , 2002, The Journal of Biological Chemistry.

[35]  S. Shapiro,et al.  Neutrophil elastase targets virulence factors of enterobacteria , 2002, Nature.

[36]  Giorgio Gabella,et al.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.

[37]  K. Botzenhart,et al.  Effects of Amoxicillin, Gentamicin, and Moxifloxacin on the Hemolytic Activity of Staphylococcus aureus In Vitro and In Vivo , 2001, Antimicrobial Agents and Chemotherapy.

[38]  S. Shapiro,et al.  Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. , 2000, Science.

[39]  T. Ley,et al.  Normal neutrophil function in cathepsin G-deficient mice. , 1999, Blood.

[40]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[41]  Ronald McCarthy,et al.  Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis , 1998, Nature Medicine.

[42]  J. Verhoef,et al.  Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. , 1991, Journal of immunology.

[43]  P. Ward,et al.  Chemotactic factor inactivators of human granulocytes. , 1977, The Journal of clinical investigation.

[44]  F. Laurent,et al.  Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.